Corey R Johnson

Title: Corey R Johnson: Innovator in Gastrointestinal Treatments

Introduction

Corey R Johnson is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of gastrointestinal microbial infections. His innovative work has led to the development of a patent that addresses critical health issues.

Latest Patents

Johnson holds a patent for "Compounds and methods for treating mammalian gastrointestinal microbial infections." This patent describes compounds and their pharmaceutically acceptable salts and prodrugs, which serve as inhibitors of IMPDH. The invention emphasizes the selective inhibition of parasitic IMPDH compared to host IMPDH. Additionally, it provides pharmaceutical compositions that include these compounds, which can be utilized in treating various parasitic and bacterial infections in mammals. The compounds may also be combined with other therapeutic agents, such as anti-virals and immunosuppressants.

Career Highlights

Throughout his career, Corey R Johnson has worked with esteemed institutions, including Brandeis University and the University of Georgia Research Foundation, Inc. His experience in these organizations has contributed to his expertise in pharmaceutical research and development.

Collaborations

Johnson has collaborated with notable colleagues, including Lizbeth K Hedstrom and Gregory D Cuny. These partnerships have likely enhanced his research and innovation efforts in the field.

Conclusion

Corey R Johnson's contributions to the treatment of gastrointestinal infections through his patented compounds highlight his role as an influential inventor in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments.